id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-294921-h44tct43	Greninger, Alexander L.	The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience	2020-07-23		.txt	text/plain	2744	121	55	Dr. Greninger was working in his research lab, assembling data for an early February grant for funding to understand the function of his favorite coronavirus gene (orf3a) in SARS-CoV-2, while Dr. Jerome continued splitting time between clinical virology and his work at the Fred Hutchinson Cancer Research Center on gene therapies for persistent viruses. From mid-January until the end of February, we received respiratory specimens from about 15 different persons under investigation for COVID-19 for respiratory virus panel testing, but each of them tested negative for SARS-CoV-2, not only at the CDC but also in our lab as we continued the evaluation of our assay. We could not report results from our assay development and validation studies, but our clinicians soon became disappointed by the 5-to 7-day turnaround time for clinical results from the CDC, during which patients waited in isolation for test results.	./cache/cord-294921-h44tct43.txt	./txt/cord-294921-h44tct43.txt